[Oppkangshi: company scleral mirror is expected to complete clinical trials in the third quarter] FAP reported on the interactive platform that the company's scleral mirror is expected to complete clinical trials in the third quarter and submit a registration declaration within this year. It can only be listed for sale after getting the registration certificate, including hospitals in Guangdong region.